The key point is that we are not doing badly. There was a kind of delay due to the COVID, but there are some countries that are really outperforming the rest of the countries. We see excellent improvement in acute stroke treatment. This is mostly the most important part that we saw. Better organization, reduction of time to treatment, and so on. Secondary prevention is something that we have to work on more, primary prevention...
The key point is that we are not doing badly. There was a kind of delay due to the COVID, but there are some countries that are really outperforming the rest of the countries. We see excellent improvement in acute stroke treatment. This is mostly the most important part that we saw. Better organization, reduction of time to treatment, and so on. Secondary prevention is something that we have to work on more, primary prevention. We increased our goal to reduce stroke by 15% from 10%. So it seems that we are doing a great job.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.